We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EXPD:NYSEExpeditors International of Washington, Inc. Analysis

Data as of 2026-05-25 - not real-time

$158.48

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Expeditors is trading firmly above its short‑term moving averages, with the price comfortably higher than the 20‑day and 50‑day trends, confirming a bullish market bias. The MACD indicator has turned bullish, reinforcing upward momentum, while the RSI sits in the upper range, hinting at potential overbought conditions. Recent earnings have outpaced expectations, delivering a profit beat and a revenue increase that aligns with the company’s modest growth trajectory. Analysts are anticipating a dividend increase, extending a nearly three‑decade streak of annual dividend hikes, which underscores the firm’s commitment to returning cash to shareholders. The payout ratio remains low, supported by strong operating cash flow and a solid balance sheet with modest leverage. However, the current market price sits well above the discounted cash‑flow derived fair value, suggesting that the stock may be priced for perfection in the near term. Volatility remains elevated, and trading volume has shown a downward trend, adding a layer of short‑term uncertainty. Despite the premium valuation, the company’s robust return on equity, healthy margins, and consistent dividend growth provide a compelling long‑term narrative. Sector dynamics in integrated freight and logistics are cyclical, with demand driven by global trade flows that can fluctuate. Overall, the blend of strong fundamentals and a potentially stretched valuation calls for a measured approach.
Investors should weigh the bullish technical setup against the valuation gap and heightened volatility. In the short run, a cautious stance is prudent, while the medium horizon benefits from the earnings momentum and dividend outlook. Over the longer horizon, the company’s cash generation and dividend sustainability support a steady‑hand position, provided price pressures ease.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and price above short‑term averages
  • RSI approaching overbought levels
  • Current price exceeds intrinsic fair value

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Quarterly earnings beat and revenue growth
  • Anticipated dividend increase reinforcing cash returns
  • Fundamentals such as ROE and operating margins remain strong

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained dividend growth and low payout ratio
  • High return on equity and solid free cash flow generation
  • Valuation premium may compress if market expectations soften

Key Metrics & Analysis

Financial Health

Revenue Growth4.40%
Profit Margin7.47%
P/E Ratio25.6
ROE36.64%
ROA14.17%
Debt/Equity24.71
P/B Ratio9.2
Op. Cash Flow$973.1M
Free Cash Flow$783.2M
Industry P/E29.7

Technical Analysis

TrendBullish
RSI61.8
Support$136.13
Resistance$159.90
MA 20$152.76
MA 50$148.08
MA 200$140.63
MACDBullish
VolumeDecreasing
Fear & Greed Index91.73

Valuation

Fair Value$99.89
Target Price$146.38
Upside/Downside-7.63%
GradeOvervalued
TypeBlend
Dividend Yield1.02%

Risk Assessment

Beta0.59
Volatility35.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.